Figure. Risk of Thromboembolic Events in Patients Not Receiving Anticoagulation Therapy After Community-Acquired Pneumonia According to Development of New-Onset Atrial Fibrillation (AF).

Patients with new-onset AF were censored when they started anticoagulation therapy and death was treated as a competing risk. Patient data were weighted by the inverse probability of censoring.